Analytical Data
-
Gene name
BZW2
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y6E2
-
Expression Region
1-419aa
-
Molecular Weight
75.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BZW2, or Basic Leucine Zipper Protein 2, is a member of the bZIP transcription factor family, which plays crucial roles in regulating various biological processes, including cell differentiation, growth, and stress response. Recent studies have highlighted the significance of BZW2 in various diseases, particularly in cancer, where it may influence tumorigenesis and metastasis through its regulatory effects on gene expression. Research has indicated that BZW2 is overexpressed in certain cancer types, suggesting its potential as a biomarker for diagnosis and prognosis. Additionally, its involvement in the modulation of immune responses has drawn attention to its therapeutic potential. The recombinant expression of BZW2 protein allows for detailed functional studies, enabling researchers to elucidate its role in cellular pathways and interactions with other proteins. Understanding the structure-function relationship of BZW2 is critical for developing targeted therapies, as its unique characteristics may provide novel insights into treatment strategies. Furthermore, exploring BZW2's molecular mechanisms can enhance the comprehension of its implications in various pathophysiological conditions, paving the way for innovative approaches in clinical applications. Overall, the study of BZW2 recombinant protein is an important avenue for advancing our understanding of transcriptional regulation and its impact on health and disease.
